Download as pdf or txt
Download as pdf or txt
You are on page 1of 3

Game Changers Cancer Immunotherapies:

Checkpoint Inhibitors
September 2015

Precision Research & Consulting Pvt. Ltd.

www.idatainsights.com

Game Changers Cancer Immunotherapies:


Checkpoint Inhibitors

1.

Executive Summary

2.

Introduction
PD-1/PD-L1 Pathway
Role of PD-1/PD-L1 Pathway
Drugs Targeting the PD-1 vs. PD-L1 Pathway
Patterns and Evaluation of Response

Table of Content (Draft)

REPORT HIGHLIGHTS
How checkpoint inhibitors are revolutionizing treatment
options and expectations for cancer patients
An overview of global melanoma market
Case studies on Opdivo, Keytruda and Yervoy
Market potential of Opdivo and Keytruda

Safety
PD-L1 Inhibitors

A MUST BUY FOR

PD-1 Inhibitors
Rationale for Combination Therapies
PD-L1 as a Predictive Biomarker
Cytotoxic T-Lymphocyte Associated Antigen (CTLA-4)
Pathway

3.

Case Study 1: Opdivo (Bristol-Myers Squibb)


Product Profile

4.

5.

Professional from the pharmaceutical, biotech, medical device and


diagnostics industries with responsibilities or involvement in the
following areas:
Competitive Intelligence
Business Intelligence
Information Specialist

Development Timeline

Commercial/Customer Insights

Clinical Trial Profiles

Strategic Planning

Pricing Scenario

Market/Marketing Research

Regulatory Scenario

Decision Analysis/Decision Support

Life Cycle Management Activities

Business Analytics

Case Study 2: Keytruda (Merck)

New Product Planning/Development

Product Profile

Forecasting

Development Timeline

Librarian

Clinical Trial Profiles

Brand Management/Product Management

Pricing Scenario

Marketing

Regulatory Scenario

Business Portfolio Planning

Life Cycle Management Activities

Strategic/Business Analysis

Case Study 3: Yervoy (Bristol-Myers Squibb)

Business Development

Product Profile

Licensing

Development Timeline

Technical Analysis

Clinical Trial Profiles

Portfolio Management/Planning

Pricing Scenario

Project Management

Regulatory Scenario

Risk Management

Life Cycle Management Activities

Research Planning

Efficacy and Safety Comparison on Opdivo,


Keytruda and Yervoy in Melanoma

Regulatory

7.

Global Melanoma Market Overview

Scientist

8.

The PD-1 Wave: Opdivo and Keytruda Market Potential

9.

KOL Comments: Analysis of Statements from Various KOLs

6.

Precision Research & Consulting Pvt. Ltd.

Research & Development

Legal/Regulatory
Outsourcing
Manufacturing

www.idatainsights.com

Game Changers Cancer Immunotherapies:


Checkpoint Inhibitors

Order Form

I wish to procure research report Game Changers Cancer Immunotherapies: Checkpoint Inhibitors priced at Rs 60,000/ 1,000 USD.
I wish to procure research report Game Changers Cancer Immunotherapies: Checkpoint Inhibitors priced at Rs 56,000 / 950 USD
as I am wishing to avail discount.
Note:

1. Additional INR 5000 / 100 USD for Hard Copy printing


2. 10% Discount till August 31st 2015

Name (Block Letters)_______________________________________________________ Designation_______________________

Company_____________________________________________________________________________________________

Mailing Address_________________________________________________________________________________________

Telephone_________________________________________ Mobile_______________________________________________

Fax_________________________________________ E-mail____________________________________________________

Wire Transfer details:

For cheque/demand draft:

Beneficiary: Precision Research and Consulting Pvt. Ltd.

I am enclosing a cheque/demand draft of

Bank Name: ICICI Bank Ltd.

INR/US$:

Bank Account No.: 664305500082

vide cheque/DD no.:

IFSC Code: ICIC0006643

drawn on:

Swift Code: ICICINBBCTS

dated:

Bank Address: J-8, Vikas Puri, New Delhi - 110018 (INDIA)

In favour of:

Contact Details:

Corporate Office:

K Venkat

Precision Research and Consulting Pvt. Ltd.

Tel: +91 - 11 - 45544187, 41630406

502, Vishwadeep Tower, District Centre,

Mobile: +91 - 8527803963

Janak Puri, New Delhi - 110058

venkat@idatainsights.com

Phone - 011 - 45544187

research@idatainsights.com

www.idatainsights.com info@idatainsights.com

www.idatainsights.com

You might also like